Development of $^{177}$ Lu-labeled albumin binder-conjugated radiopharmaceutical targeting fibroblast activation protein

Saito, Kosuke*; Watanabe, Hiroyuki*; Nakashima, Kazuma*; Hashimoto, Kazuyuki; Chiba, Yusuke; Fujino, Shunsuke; Kawauchi, Yukimasa*; Saeki, Hideya*; Takashima, Naoki*; Kawabata, Masako*; Ono, Masahiro*

no abstracts in English

Language	:	Japanese
Journal	:
Volume	:
Number	:
Pages	:
Publication Year/Month	:
Meeting title	:	第65回日本核医学会学術総会/第45回日本核医学技術学会総会学術大会
Held date	:	2025/11
Location (city)	:	京都
Location (country)	:	日本
Patent information	:
PDF	:
Paper URL	:
DOI for research data	:	Link to research data related to this paper/report.
Keywords	:	Lu-177
Research Facility	:	JRR-3M(研究炉3) ;RI製造棟
Press Release	:
JAEA R&D Navigator	:
Cooperating Institute	:	京都大学; 千代田テクノル

Accesses	:	- Accesses
Web of Science® Times Cited Count	:	Times Cited Count： If you would like to get the latest times cited, please access the Web of Science®. http://www.webofknowledge.com/wos
InCites™	:
Altmetrics	:

Registration No. : BB20251275
JAEA Abstracts No. :
Paper Submission No. :

[CLARIVATE ANALYTICS], [WEB OF SCIENCE], [HIGHLY CITED PAPER & CUP LOGO] and [HOT PAPER & FIRE LOGO] are trademarks of Clarivate Analytics, and/or its affiliated company or companies, and used herein by permission and/or license.

Development of Lu-labeled albumin binder-conjugated radiopharmaceutical targeting fibroblast activation protein

Development of $^{177}$ Lu-labeled albumin binder-conjugated radiopharmaceutical targeting fibroblast activation protein